Evaluate the Effect of Injectable Neucardin on the Cardiac Function of Subjects With Chronic Systolic Heart Failure

NCT04468529 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Systolic Heart Failure

Interventions

DRUG: Recombinant human Neuregulin for injection
DRUG: Placebo

Sponsor

Zensun Sci. & Tech. Co., Ltd.